ALL vs IMA · P/E 4.9, $56.89B cap vs rev $9.2M
The Allstate Corporation (ALL) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
ALL does not have a complete income-statement cache yet.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. IMA currently screens at market cap $64.7M.
Not investment advice. Open the ALL and IMA stock pages for the full models.
Not investment advice.